HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid productsApril 1, 2022
Clinical Criteria updates
Please note, this communication applies to Anthem HealthKeepers Plus, Medallion and Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) offered by HealthKeepers, Inc.
On November 19, 2021, December 13, 2021, and January 10, 2022, the Pharmacy and Therapeutics (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for
HealthKeepers, Inc. These policies were developed, revised, or reviewed to support clinical coding edits.
Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.
Please see the explanation/definition for each category of Clinical Criteria below:
- New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive
Please share this notice with other members of your practice and office staff.
Please note: The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
Effective date |
Document number |
Clinical Criteria title |
New or revised |
April 8, 2022 |
*ING-CC-0205 |
Fyarro (sirolimus albumin bound) |
New |
April 8, 2022 |
*ING-CC-0206 |
Besremi (ropeginterferon alfa-2b-njft) |
New |
April 8, 2022 |
*ING-CC-0207 |
Vyvgart (efgartigimod alfa-fcab) |
New |
April 8, 2022 |
*ING-CC-0208 |
Adbry (tralokinumab) |
New |
April 8, 2022 |
*ING-CC-0209 |
Leqvio (inclisiran) |
New |
April 8, 2022 |
ING-CC-0124 |
Keytruda (pembrolizumab) |
Revised |
April 8, 2022 |
ING-CC-0079 |
Strensiq (Asfotase Alfa) |
Revised |
April 8, 2022 |
ING-CC-0102 |
Gonadotropin releasing hormone (GNRH) Analogs for Oncologic Indications |
Revised |
April 8, 2022 |
ING-CC-0168 |
Tecartus (brexucabtagene autoleucel) |
Revised |
April 8, 2022 |
*ING-CC-0004 |
Repository Corticotropin Injection |
Revised |
April 8, 2022 |
ING-CC-0072 |
Selective Vascular Endothelial Growth Factor (VEGF) Antagonists |
Revised |
If you have any questions about this communication, call Anthem HealthKeepers Plus, Medallion Provider Services at 800‑901‑0020 or Anthem CCC Plus Provider Services at 855‑323‑4687.
PUBLICATIONS: April 2022 Anthem Provider News - Virginia
To view this article online:
Visit https://providernews.anthem.com/virginia/articles/clinical-criteria-updates-50-10382
Or scan this QR code with your phone